In a release issued today by The Rosen Law Firm, P.A. under the headline "INO FINAL DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Reminds Inovio Pharmaceuticals, Inc. Investors of Important May 11 Deadline in Securities Class Action Lawsuit - INO," please note the lead plaintiff deadline stated as May 11, 2020 should be May 12, 2020. The corrected release follows:
INO FINAL DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Reminds Inovio Pharmaceuticals, Inc. Investors of Important May 12 Deadline in Securities Class Action Lawsuit - INO
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between February 14, 2020 and March 9, 2020, inclusive (the "Class Period") of the important May 12, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Inovio investors under the federal securities laws.
To join the Inovio class action, go to http://www.rosenlegal.com/cases-register-1807.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email email@example.com or firstname.lastname@example.org for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR'S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses. When the market learned the truth about Inovio, investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 12, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1807.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at email@example.com or firstname.lastname@example.org.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney advertising. Prior results do not guarantee a similar outcome.
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40 Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827